Compare ADMA Biologics Inc (ADMA) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.41. Which is the better fit depends on your goals.
| ADMA | YMAG | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $20.38 | $15.98 |
52-Week Low | $7.60 | $10.76 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
